Alex Nowbar

A wholesome week spent in the beautiful Lindau with some amazing people 💙 #LINO23 @lindaunobel

Last day at Lindau 🥲 Met some wonderful people #LINO23 @LaurenOwens97 @kayeshac1 @lindaunobel @MadeleineHeep

Day 1 of Lindau Nobel Laureate Meeting 2023. Honoured to be a part of this unique event #LINO23 @lindaunobel Thank you to @MarsGlobal and @ImperialNHLI for supporting me.

The OphanTalent Academy #Sciathon project by Lindau Alumna Crina Samarghitean wants to connect orphan children all over the world with orphan rare diseases patients and the best researchers in the world. Help them by taking this survey: ow.ly/mpt450O2KsK

I am proud to be taking part in #Sciathon #LINO23 with @CSamarghitean and @MadeleineHeep Our project aims to connect orphan children all over the world with orphan rare diseases patients and the best researchers in the world.

Do you design AI-based educational tools? Do you work in orphan diseases? Would you like to be a mentor? Do you have links with orphan charities? Fill out this survey tinyurl.com/2nnvua4s #sciathon #LINO23

My best one? Auditing the use of continuous ECG monitoring on AMU. We've done this audit 3-4 times. @AlexNowbar @CJBeattie1991 Only when we implemented IT-based reminders, with buy-in from the head of the site operations team, did things start to improve.

Great to see this in print: methods paper for ORBITA-2. Trial is progressing well thanks to @rallamee @AlexNowbar & the whole team 👍

ORBITA-2 will provide placebo-controlled data on the efficacy of PCI on symptoms in patients off antianginal medications. An ordinal clinical outcome scale for angina was designed in partnership with patients to be a relevant and inclusive primary outcome. eurointervention.pcronline.com/article/a-doub…

Zack asked the audience ‘what does a good medical registrar look like’ and someone wrote ‘sexy’

Excited to say the SAMSON Trial's full data has now been published in @JACCJournals. There is lots of interesting data, such as the remarkably similar timecourses of symptom onset and offset when starting and stopping statins and placebo jacc.org/doi/10.1016/j.…

Calling everyone in UK that cares about the NHS. When a drug goes off patent, it becomes cheap, yeh? No. If there is only one manufacturer they can screw us over for millions. Please sign Karim Meeran's petition to the government which will fix this. petition.parliament.uk/petitions/5937…

Angina is a strange beast. rwjms1.umdnj.edu/shindler/heber…

Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding ⁦@rallamee⁩ ⁦@ProfDFrancis⁩ ⁦@AlexNowbar⁩ link.springer.com/article/10.100…

Our latest coronary physiology paper online now @EuroInterventio. You must have heard or read before that "flow in the right coronary artery can be predominantly systolic". True, a myth or a case report bias? We investigated this formally in the large IDEAL study dataset. 1/n

The Lowdown on the Left Atrial Appendage Occlusion Study III: an Interview with Gerhard Hindricks and Thomas F. Deering cvctcardiobrief.com/the-lowdown-on…

#CVCT2021 Scientific Program is out there ! Go check now & register : globalcvctforum.com/scientific-pro… #CVCT @Drroxmehran @hvanspall @CMichaelGibson @penilla @JavedButler1 @cardiobrief @drdargaray @KevinShahMD @vbluml @AlexNowbar @rachkataria @DrRajivsankar @ersied727 @SantosGallegoMD

Thoughts about the use of the Win Ratio in Cardiovascular Outcome Trials cvctcardiobrief.com/thoughts-about…

Thank you to @HelenRoutledge2, Andy Epstein and the team at Worcestershire Acute Hospitals NHS Trust for randomising the 100th patient into ORBITA-2. Amazing work! @rajkumar_chris @AlexNowbar @MikeFoley89

A Pragmatic Trial isn’t just a Simple Trial: An Interview with Colin Baigent about ADAPTABLE cvctcardiobrief.com/a-pragmatic-tr…